Loading insider details...
Beta
Latest Form 4 (Jun 12, 2026): Grant/Award of 14,000 OCUL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | OCULAR THERAPEUTIX, INC (OCUL) | Grant/Award | 14,000 | n/a |
| Jun 5, 2026 | LENSAR, Inc. (LNSR) | Grant/Award | 17,421 | n/a |
| Feb 24, 2026 | OCULAR THERAPEUTIX, INC (OCUL) | Purchase | 60,229 | $461.4K |
| Jun 13, 2025 | OCULAR THERAPEUTIX, INC (OCUL) | Grant/Award | 14,000 | n/a |
| May 28, 2025 | LENSAR, Inc. (LNSR) | Grant/Award | 7,374 | n/a |
| May 13, 2025 | OCULAR THERAPEUTIX, INC (OCUL) | Purchase | 10,000 | $69.6K |
| Jul 26, 2024 | OCULAR THERAPEUTIX, INC (OCUL) | Exercise/Conversion | 18,939 | $166.7K |
| May 9, 2024 | LENSAR, Inc. (LNSR) | Grant/Award | 22,000 | n/a |
| Jun 16, 2023 | OCULAR THERAPEUTIX, INC (OCUL) | Grant/Award | 12,000 | n/a |
| May 30, 2023 | LENSAR, Inc. (LNSR) | Grant/Award | 9,288 | n/a |